Evidence map›Paper›PMID 39271653›Full record

ArticleNature communications2024

Metformin hydrolase is a recently evolved nickel-dependent heteromeric ureohydrolase.

M Sinn, L Riede, J R Fleming, D Funck, H Lutz, A Bachmann, O Mayans, J S Hartig

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

M SinnDepartment of Chemistry, University of Konstanz, Konstanz, Germany. malte.sinn@uni-konstanz.de.ORCID 0000-0002-3790-9686
L RiedeDepartment of Chemistry, University of Konstanz, Konstanz, Germany.
J R FlemingDepartment of Biology, University of Konstanz, Konstanz, Germany.
D FunckDepartment of Chemistry, University of Konstanz, Konstanz, Germany.ORCID 0000-0002-9855-0419
H LutzDepartment of Biology, University of Konstanz, Konstanz, Germany.ORCID 0009-0007-1328-4371
A BachmannDepartment of Biology, University of Konstanz, Konstanz, Germany.
O MayansDepartment of Biology, University of Konstanz, Konstanz, Germany.
J S HartigDepartment of Chemistry, University of Konstanz, Konstanz, Germany. joerg.hartig@uni-konstanz.de.ORCID 0000-0001-6601-7217

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The anti-diabetic drug metformin is one of the most widely prescribed medicines in the world. Together with its degradation product guanylurea, it is a major pharmaceutical pollutant in wastewater treatment plants and surface waters. An operon comprising two genes of the ureohydrolase family in Pseudomonas and Aminobacter species has recently been implicated in metformin degradation. However, the corresponding proteins have not been characterized. Here we show that these genes encode a Ni

Indexed as

MetforminNickelBacterial ProteinsBiodegradation, EnvironmentalCatalytic DomainCrystallography, X-RayHydrolysisModels, MolecularPseudomonasUreohydrolasesBacterial ProteinsMetforminNickelUreohydrolases

Identifiers

PMID39271653
PMCPMC11399263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.